Product Overview
Olverembatinib dimesylate | T2429 | TargetMol Chemicals
CAS: 1421783-64-3
Smiles: CS(O)(=O)=O.CS(O)(=O)=O.CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc3cnc4[nH]ncc4c3)cc2C(F)(F)F)CC1
Formula: C31H35F3N6O7S2
Pathway: Angiogenesis|||Cytoskeletal Signaling|||Tyrosine Kinase/Adaptors
Target: Bcr-Abl
Receptor: N/A
Bioactivity: GZD824 Dimesylate is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I).
Molecular Weight: 724, 77
